Latest Venous ulcer Stories
FORT WORTH, Texas, Feb. 1, 2013 /PRNewswire/ -- Healthpoint Biotherapeutics, a Smith & Nephew business (LSE: SN, NYSE: SNN), today announced the introduction of a Copay Assistance Program for patients who have been prescribed Collagenase SANTYL(®) Ointment and pay more than $50 out-of-pocket for their prescription. Under the program, eligible patients cover the first $50 and Healthpoint will pay up to the next $150 of out-of-pocket costs per prescription. The card can be used...
ADDISON, Texas, Jan. 14, 2013 /PRNewswire/ -- ULURU Inc. (OTCQB: ULUR) announced today the availability in the U.S. market of Altrazeal(®) in an innovative 0.75 gram blister pack. The development of this innovative packaging system was in response to requests from wound care practitioners. This packaging configuration overcomes the concerns expressed by users, including excessive waste of product, inability to see the product during application and unit cost for the treatment of...
Dr. Cindy Asbjornsen, founder of the Vein Healthcare Center in Maine, explains why patients with vein problems should seek help in the new year. South Portland, Maine (PRWEB) January 09, 2013 At the start of a new year, many people schedule visits to their family doctor, dentist and other physicians, but who should plan to visit a vein doctor, and why? According to vein specialist Dr. Cindy Asbjornsen of the Vein Healthcare Center, people often discount their bulging or uncomfortable...
SAN DIEGO, Jan. 9, 2013 /PRNewswire/ -- CoDa Therapeutics, Inc. today announced positive results from a Phase 2b clinical trial of NEXAGON(®) in patients with chronic venous leg ulcers. NEXAGON(®) is an easy to administer, once-a-week, topical, drug candidate being developed for the treatment of chronic wounds. It is designed to increase the incidence of wound healing compared to existing therapeutic techniques, and to heal them much faster. The company believes these results...
ADDISON, Texas, Jan. 8, 2013 /PRNewswire/ -- ULURU Inc. (OTCQB: ULUR) announced today the first shipment of the 0.75 gram blister pack to our Austrian marketing partner. The extensive clinical experience in Austria has established a significant platform from which to rapidly penetrate this market. Both clinical and economic benefits have been established in the use of Altrazeal(®) in patients with acute and chronic wounds. Commenting on the launch of Altrazeal(® )in Austria,...
SAN DIEGO, Jan. 3, 2013 /PRNewswire/ -- Cardium Therapeutics (NYSE MKT: CXM) today announced a distribution agreement with Academy Medical, LLC to market, sell and distribute Excellagen to U.S. government medical providers, including the Veterans Administration (VA) healthcare system and military hospitals. Excellagen is FDA-cleared, to support advanced wound care in a broad range of dermal wounds. Academy Medical's initial focus will be to provide education and training on the use...
Dr. Cindy Asbjornsen, vein specialist and founder of the Vein Healthcare Center in Maine, offers tips on making the most of graduated compression therapy. South Portland, Maine (PRWEB) December 27, 2012 Venous disease— a condition that can include varicose veins, spider veins, or deep vein thrombosis— is one of the most common health problems in the U.S. According to Dr. Cindy Asbjornsen of the Vein Healthcare Center in Maine, there are several options for conservative treatment of...
Specializing in improving the quality of life for those suffering from venous and lymphatic diseases, BSN Medical develops and manufactures products used in the care and management of afflictions like varicose veins, chronic venous insufficiency, deep vein thrombosis, venous ulcers, peripheral edemas and lymphodema. As the number one physician-recommended brand of compression hosiery in the USA, the JOBST® brand from BSN Medical sets the standard for quality and is recognized and...
NESS ZIONA, Israel, December 17, 2012 /PRNewswire/ -- CollPlant (TASE:CLPT) designer and manufacturer of medical products based on a recombinant protein sourced from tobacco plants, announced today that it received CE mark approval for European sale and marketing of its Vergenix(R)WD product, a company-developed wound healing product. Vergenix(R)WD is based on CollPlant's recombinant human collagen to treat patients with lower limb ulcer. Yehiel Tal, CollPlant's CEO:...
Dr. Cindy Asbjornsen of the Vein Healthcare Center in Maine discusses ways to promote healthy legs this holiday season. South Portland, ME (PRWEB) December 11, 2012 Approximately half of the U.S. population has some form of venous disease, which includes (but is not limited to) varicose veins. According to Dr. Cindy Asbjornsen of the Vein Healthcare Center in Maine, there’s plenty one can do to alleviate the symptoms of vein disease and prevent them from getting worse. “Venous...
